News

conference

Apr 8, 2024

2024 - AACR

Click chemistry enabled selective activation of highly cytotoxic MMAE payload at tumors using TROP2 targeting agent

press

Apr 5, 2024

Press Release

Shasqi to Present Data on Novel Tumor-Targeted Drug Activation Technology at 2024 American Association for Cancer Research (AACR) Annual Meeting

conference

Mar 17, 2024

2024 - ACS

MMAE payload uncoupled from HER2 targeting agent is selectively activated at tumors through click chemistry in vivo

press

Mar 11, 2024

Press release

Shasqi Appoints Travis Biechele, Ph.D. as VP of Research to Lead Pipeline Development

press

Mar 5, 2024

Press release

Shasqi to Present New Data at 2024 World ADC London Conference

press

Jan 4, 2024

Press release

Shasqi Expands Board of Directors with Appointment of Biopharma Executives

conference

Oct 23, 2023

2023 - ESMO

Phase 1 Clinical Results of SQ3370, a Doxorubicin-based Click Chemistry Therapeutic in Advanced Solid Tumor Patients

conference

Oct 16, 2023

2023 - World ADC

MMAE payload separated from HER2 targeting agent is selectively activated at tumors through click chemistry in vivo

media

Oct 12, 2023

Drug Discovery World

Click chemistry breakthroughs drive Shasqi and J&J cancer alliance

media

Oct 5, 2023

Drug Discovery World

Nobel-connected startup Shasqi deepens J&J partnership on CAPAC platform

press

Oct 4, 2023

Press release

Shasqi to Expand Existing Research Collaboration to Advance Targeted Cancer Treatment

press

Aug 2, 2023

Press Release

Shasqi Appoints Oncology Luminaries to its Inaugural Scientific Advisory Board, Alongside the Expansion of its Leadership Team